Market Tracker

01/20 5:16pm ET

Pluristem Therapeutics Inc (NASDAQ:PSTI)

1.15
Delayed Data
As of Jan 20
 -0.25 / -17.86%
Today’s Change
0.71
Today|||52-Week Range
1.85
-19.58%
Year-to-Date
Flood of News Presents Buying Opportunity
Jan 17 / GuruFocus News - Paid Partner Content
Pluristem (PSTI) Intermittent Claudication Study Enrolled
Jan 13 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close1.40
Today’s open1.08
Day’s range1.04 - 1.16
Volume8,872,459
Average volume (3 months)224,461
Market cap$93.8M
Dividend yield--
Data as of 4:00pm ET, 01/20/2017

Growth & Valuation

Earnings growth (last year)+17.14%
Earnings growth (this year)--
Earnings growth (next 5 years)+1.00%
Revenue growth (last year)+651.19%
P/E ratioNM
Price/Sales37.16
Price/Book2.42

Competitors

 Today’s
change
Today’s
% change
BPTHBio Path Holdings In...+0.03+2.98%
AXSMAxsome Therapeutics ...-0.10-1.98%
SNESSenesTech Inc-0.59-6.22%
AKTXAkari Therapeutics P...-0.53-6.63%
Data as of 4:00pm ET, 01/20/2017

Financials

Next reporting dateFebruary 3, 2017
EPS forecast (this quarter)-$0.08
Annual revenue (last year)$2.8M
Annual profit (last year)-$23.2M
Net profit margin-816.51%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Zami Aberman
President, COO, CFO, Secretary &
Director
Yaky Yanay
Corporate headquarters
Haifa, Haifa

Forecasts